Literature DB >> 3041142

Enhanced binding of morphine and nalorphine to opioid delta receptor by glucuronate and sulfate conjugations at the 6-position.

K Oguri, I Yamada-Mori, J Shigezane, T Hirano, H Yoshimura.   

Abstract

Effect of the modification of morphine and nalorphine by glucuronate and sulfate conjugations at the 3- and 6-positions on the binding to opioid receptors was examined in a particulate fraction of rat brain. Competing potencies of both drugs against [3H]morphine and [3H]leucine enkephalin bindings were extremely decreased by either glucuronate or sulfate conjugation at the 3-position. On the other hand, the potencies of morphine and nalorphine against [3H]leucine enkephalin binding were considerably enhanced by the conjugations at the 6-position, whereas the potencies against [3H]morphine binding were decreased. These altered interactions of the conjugates at the 6-position with the two ligands were attributed to their enhanced binding to delta-receptor and reduced binding to mu-receptor by Hill plot and modified Scatchard analysis. Resulted comparable and simultaneous interactions with mu- and delta- receptors were assumed to be a cause of the enhanced mu-receptor-directed analgesia of morphine and elevated same receptor-directed antagonistic effect of nalorphine, which have been found previously in our laboratory.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3041142     DOI: 10.1016/0024-3205(87)90710-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  16 in total

Review 1.  Role of active metabolites in the use of opioids.

Authors:  Janet K Coller; Lona L Christrup; Andrew A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  2008-10-29       Impact factor: 2.953

2.  Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.

Authors:  Jai Shankar K Yadlapalli; Benjamin M Ford; Amit Ketkar; Anqi Wan; Narasimha R Penthala; Robert L Eoff; Paul L Prather; Maxim Dobretsov; Peter A Crooks
Journal:  Pharmacol Res       Date:  2016-09-13       Impact factor: 7.658

3.  [The role of morphine-6-glucuronide during longterm administration of morphine.].

Authors:  M Prokopek; A Ziegler
Journal:  Schmerz       Date:  1992-03       Impact factor: 1.107

4.  Long lasting respiratory depression induced by morphine-6-glucuronide?

Authors:  J Hasselström; U Berg; A Löfgren; J Säwe
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

5.  Evaluation of Analgesia, Tolerance, and the Mechanism of Action of Morphine-6-O-Sulfate Across Multiple Pain Modalities in Sprague-Dawley Rats.

Authors:  Jai Shankar K Yadlapalli; Navdeep Dogra; Anqi W Walbaum; William D Wessinger; Paul L Prather; Peter A Crooks; Maxim Dobretsov
Journal:  Anesth Analg       Date:  2017-09       Impact factor: 5.108

6.  Morphine has latent deleterious effects on the ventilatory responses to a hypoxic challenge.

Authors:  Walter J May; Ryan B Gruber; Joseph F Discala; Veljko Puskovic; Fraser Henderson; Lisa A Palmer; Stephen J Lewis
Journal:  Open J Mol Integr Physiol       Date:  2013-11

7.  Affinity profiles of novel delta-receptor selective benzofuran derivatives of non-peptide opioids.

Authors:  M Spetea; S T Nevin; S Hosztafi; A Z Rónai; G Tóth; A Borsodi
Journal:  Neurochem Res       Date:  1998-09       Impact factor: 3.996

8.  Pharmacokinetics of nicomorphine and its metabolites in man after epidural administration.

Authors:  P M Koopman-Kimenai; T B Vree; M A Hasenbos; E W Weber; C P Verweij-Van Wissen; L H Booij
Journal:  Pharm Weekbl Sci       Date:  1991-06-21

9.  The pharmacokinetics of codeine and its metabolites in Blacks with sickle cell disease.

Authors:  Stacy S Shord; Larisa H Cavallari; Weihua Gao; Hyun-Young Jeong; Kelly Deyo; Shitalben R Patel; Joseph R Camp; Susan M Labott; Robert E Molokie
Journal:  Eur J Clin Pharmacol       Date:  2009-04-09       Impact factor: 2.953

10.  Morphine 6-glucuronide: a metabolite of morphine with greater emetic potency than morphine in the ferret.

Authors:  P I Thompson; S Bingham; P L Andrews; N Patel; S P Joel; M L Slevin
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.